Cambridge Healthtech Institute’s 2nd Annual

Targeting Fibrosis

Developing Medical Therapies for Fibrotic Diseases

September 17-18, 2020

 

CHI’s 2nd Annual Targeting Fibrosis conference will follow the model of last year’s successful launch by covering a mix of drug discovery successes and development challenges in the field of fibrosis. Presentations will focus on new molecular entities being targeted by small molecules, biologics, or newer modalities that show potential for reducing organ fibrosis. Most of the compounds with clinical success are in the lung, so much of the conference will focus on that organ. However, fibrosis of the kidney, skin, and other organs may also be covered to assess common scarring mechanisms and molecular pathways. Liver fibrosis will mostly be covered in the preceding NASH conference at this Discovery on Target event. We hope you can join us to share progress and discuss future directions in the field of fibrosis, an area whose disease burden is steadily increasing as the population of elderly, and thus chronic disease and inflammation, rises.

At Discovery on Target, this Fibrosis conference will be preceded by a 1.5-day conference on the related topic of NASH.

Who should attend: Immunologists, Discovery Biologists, Pharmacologists, Discovery Chemists in Pharma, Biotech and Academic Departments such as: Fibrosis, Inflammation, Autoimmunity, Pharmacology, Metabolism, Lung Disease.

 

Coverage will include, but is not limited to:                                        

  • Emerging fibrosis targets: TGF-β, integrins, galectin, GPCRs, growth factors, extracellular matrix components, and more
  • Common targets between fibrosis and inflammation: ROCK, LOXL2
  • Drug development challenges in fibrosis-prone organs: IPF of lung, kidney, skin, heart
  • Cellular assays for fibrosis: co-cultures, 3D cell models, explants
  • Fibrosis biomarkers
  • Connections with oncology: fibrosis in the stroma of tumors

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is February 26, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252

Email: ashah@healthtech.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286

Email: reymael@healthtech.com